Canton Hathaway’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-16,900
Closed -$121K – 266
2024
Q3
$121K Sell
16,900
-4,100
-20% -$29.1K 0.03% 116
2024
Q2
$154K Buy
+21,000
New +$183K 0.04% 102
2024
Q1
– Sell
-8,050
Closed -$56K – 257
2023
Q4
$56K Buy
+8,050
New +$53.5K 0.02% 152
2023
Q2
– Sell
-19,000
Closed -$108K – 246
2023
Q1
$108K Buy
+19,000
New +$126K 0.04% 107
2022
Q1
– Sell
-3,300
Closed -$84K – 277
2021
Q4
$84K Buy
3,300
+2,300
+230% +$63.5K 0.02% 148
2021
Q3
$32K Sell
1,000
-9,000
-90% -$312K 0.01% 227
2021
Q2
$400K Buy
+10,000
New +$406K 0.12% 82

Other funds holding MSOS

Canton Hathaway's MSOS Position: Q4 2024 in Review

Canton Hathaway sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2024, closing a stake of 16,900 shares — an estimated $121K sold.

Canton Hathaway first reported a position in MSOS in Q2 2021 and held it in 7 quarters. The position peaked at $400K in Q2 2021. 178 funds tracked by Wall St. Rank hold MSOS as of Q4 2024.

  • Canton Hathaway reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2024 after selling out during the quarter.
  • Canton Hathaway sold 16,900 AdvisorShares Pure US Cannabis ETF shares in Q4 2024, an estimated $121K.
  • Canton Hathaway first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and held it in 7 quarters.
  • Canton Hathaway's AdvisorShares Pure US Cannabis ETF position peaked at $400K in Q2 2021.
  • 178 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2024.

Based on Canton Hathaway's 13F filing for Q4 2024, filed 4 Feb 2025.